<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn></journal-meta><article-meta><article-id pub-id-type="pmid">350254</article-id><article-id pub-id-type="pmc">2009630</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Allocation of patients to treatment groups in a controlled clinical study.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>White</surname><given-names>S. J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Freedman</surname><given-names>L. S.</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><month>5</month><year>1978</year></pub-date><volume>37</volume><issue>5</issue><fpage>849</fpage><lpage>857</lpage><abstract><p>In a controlled clinical study ("clinical trial") to compare 2 or more treatments for a disease, an objective method of allocating patients to treatment groups is needed. Various existing methods of allocation are described, including those which take account of patients' pre-treatment characteristics.</p></abstract></article-meta></front><body><supplementary-material content-type="scanned-pages"><graphic xlink:href="brjcancer00163-0194.tif" xlink:title="scanned-page" xlink:role="849" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00163-0195.tif" xlink:title="scanned-page" xlink:role="850" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00163-0196.tif" xlink:title="scanned-page" xlink:role="851" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00163-0197.tif" xlink:title="scanned-page" xlink:role="852" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00163-0198.tif" xlink:title="scanned-page" xlink:role="853" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00163-0199.tif" xlink:title="scanned-page" xlink:role="854" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00163-0200.tif" xlink:title="scanned-page" xlink:role="855" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00163-0201.tif" xlink:title="scanned-page" xlink:role="856" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00163-0202.tif" xlink:title="scanned-page" xlink:role="857" mimetype="image" mime-subtype="tiff"/></supplementary-material></body></article>

